Literature DB >> 20590678

Identifying unpredicted drug benefit through query of patient experiential knowledge: a proof of concept web-based system.

Jill Pulley1, Nik Nik Hassan, Gordon R Bernard, Jim N Jirjis, Jonathan Schildcrout, David Robertson, Daniel R Masys, Paul Harris.   

Abstract

Information necessary to recognize unexpected drug efficacy is not routinely collected. Once a drug is approved, opportunities for understanding these phenomena are usually lost within clinical care. We propose that patients are willing to provide a wide range of experiential knowledge about the effects of therapies that is seldom solicited. Experience with various drug therapies might be solicited directly from patients in both structured and unstructured formats. Although the signal to noise ratio is expected to be low, these data, if organized in a constructive manner, could provide a useful hypothesis generation resource for areas of further pharmacologic inquiry. A pilot study was conducted for 18 months; 1,065 individuals using the MyHealthAtVanderbilt.com patient portal clicked on a research link to find more information about the study; 375 completed the survey (response rate of 37%). Of those, 218 patients reported that they were currently taking at least one prescription. Statistical methods applied detected known associations between drugs and their intended effects. This validated the type and frequency of effects being reported by patients and provided evidence for the potential for using patient-supplied information to generate hypotheses related to unexpected positive benefits associated with medications. Improved data filtering and mining methods will be needed to expand this concept.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20590678      PMCID: PMC2910903          DOI: 10.1111/j.1752-8062.2010.00200.x

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


  9 in total

1.  Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports.

Authors:  S J Evans; P C Waller; S Davis
Journal:  Pharmacoepidemiol Drug Saf       Date:  2001 Oct-Nov       Impact factor: 2.890

Review 2.  Quantitative methods in pharmacovigilance: focus on signal detection.

Authors:  Manfred Hauben; Xiaofeng Zhou
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

3.  Disproportionality analysis using empirical Bayes data mining: a tool for the evaluation of drug interactions in the post-marketing setting.

Authors:  June S Almenoff; William DuMouchel; L Allen Kindman; Xionghu Yang; David Fram
Journal:  Pharmacoepidemiol Drug Saf       Date:  2003-09       Impact factor: 2.890

4.  The loss of serendipity in psychopharmacology.

Authors:  Donald F Klein
Journal:  JAMA       Date:  2008-03-05       Impact factor: 56.272

5.  The experiential knowledge of patients: a new resource for biomedical research?

Authors:  J Francisca Caron-Flinterman; Jacqueline E W Broerse; Joske F G Bunders
Journal:  Soc Sci Med       Date:  2004-12-21       Impact factor: 4.634

6.  A Bayesian neural network method for adverse drug reaction signal generation.

Authors:  A Bate; M Lindquist; I R Edwards; S Olsson; R Orre; A Lansner; R M De Freitas
Journal:  Eur J Clin Pharmacol       Date:  1998-06       Impact factor: 2.953

Review 7.  The history of the development of minoxidil.

Authors:  G R Zins
Journal:  Clin Dermatol       Date:  1988 Oct-Dec       Impact factor: 3.541

8.  Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations.

Authors:  Hélène François; Eric Daugas; Albert Bensman; Pierre Ronco
Journal:  Am J Kidney Dis       Date:  2007-01       Impact factor: 8.860

9.  Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.

Authors:  Ana Szarfman; Joseph M Tonning; Jonathan G Levine; P Murali Doraiswamy
Journal:  Pharmacotherapy       Date:  2006-06       Impact factor: 4.705

  9 in total
  2 in total

1.  Secondary use of clinical data: the Vanderbilt approach.

Authors:  Ioana Danciu; James D Cowan; Melissa Basford; Xiaoming Wang; Alexander Saip; Susan Osgood; Jana Shirey-Rice; Jacqueline Kirby; Paul A Harris
Journal:  J Biomed Inform       Date:  2014-02-14       Impact factor: 6.317

2.  The Mid-South clinical Data Research Network.

Authors:  S Trent Rosenbloom; Paul Harris; Jill Pulley; Melissa Basford; Jason Grant; Allison DuBuisson; Russell L Rothman
Journal:  J Am Med Inform Assoc       Date:  2014-05-12       Impact factor: 4.497

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.